HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard J. Novick Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Novick, R. J. Articles by Lewis, J. F. Search for Related Content PubMed PubMed Citation Articles by Novick, R. J. Articles by Lewis, J. F.

J Thorac Cardiovasc Surg 1997;113:342-353
© 1997 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

MITIGATION OF INJURY IN CANINE LUNG GRAFTS BY EXOGENOUS SURFACTANT THERAPY

Supported by the Heart and Stroke Foundation of Ontario, the Ontario Thoracic Society, and the MultiOrgan Transplant Service, London Health Sciences Center.

Received for publication May 17, 1996 revisions requested July 22, 1996; revisions received Sept. 16, 1996 accepted for publication Sept. 18, 1996. Address for reprints: Richard J. Novick, MD, Division of Cardiovascular-Thoracic Surgery, London Health Sciences Center, University Campus, P.O. Box 5339, London, Ontario, Canada N6A 5A5.

Abstract

Background: Exogenous surfactant therapy of lung donors improves the preservation of normal canine grafts. The current study was designed to determine whether exogenous surfactant can mitigate the damage in lung grafts induced by mechanical ventilation before procurement. Methods and results: Five donor dogs were subjected to 8 hours of mechanical ventilation (tidal volume 45 ml/kg). This produced a significant decrease in oxygen tension (p = 0.007) and significant increases in bronchoscopic lavage fluid neutrophil count (p = 0.05), protein concentration (p = 0.002), and the ratio of poorly functioning small surfactant aggregates to superiorly functioning large aggregates (p = 0.02). Five other animals given instilled bovine lipid extract surfactant and undergoing mechanical ventilation in the same manner demonstrated no significant change in oxygen tension values, lavage fluid protein concentration, or the ratio of small to large aggregates. All 10 lung grafts were then stored for 17 hours at 4° C. Left lungs were transplanted and reperfused for 6 hours. After 6 hours of reperfusion the ratio of oxygen tension to inspired oxygen fraction was 307 ± 63 mm Hg in lung grafts administered surfactant versus 73 ± 14 mm Hg in untreated grafts (p = 0.007). Furthermore, peak inspired pressure was significantly (p < 0.05) lower in treated animals from 90 to 360 minutes of reperfusion. Analysis of lavage fluid of transplanted grafts after reperfusion revealed small to large aggregate ratios of 0.17 ± 0.04 and 0.77 ± 0.17 in treated versus untreated grafts, respectively (p = 0.009). Conclusions: Instillation of surfactant before mechanical ventilation reduced protein leak, maintained a low surfactant small to large aggregate ratio, and prevented a decrease of oxygen tension in donor animals. After transplantation, surfactant-treated grafts had superior oxygen tension values and a higher proportion of superiorly functioning surfactant aggregate forms in the air space than untreated grafts. Exogenous surfactant therapy can protect lung grafts from ventilation-induced injury and may offer a promising means to expand the donor pool.

This article has been cited by other articles:

				C. Muhlfeld, I-M. Schaefer, L. Becker, C. Bussinger, M. Vollroth, A. Bosch, R. Nagib, N. Madershahian, J. Richter, T. Wahlers, et al. Pre-ischaemic exogenous surfactant reduces pulmonary injury in rat ischaemia/reperfusion Eur. Respir. J., March 1, 2009; 33(3): 625 - 633. [Abstract] [Full Text] [PDF]

				A. Amital, D. Shitrit, Y. Raviv, M. Saute, I. Bakal, B. Medalion, and M. R. Kramer Surfactant as salvage therapy in life threatening primary graft dysfunction in lung transplantation Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 299 - 303. [Abstract] [Full Text] [PDF]

				N. P. van der Kaaij, J. Kluin, J. J. Haitsma, M. A. den Bakker, B. N. Lambrecht, B. Lachmann, R. W.F. de Bruin, and A. J.J.C. Bogers Surfactant pretreatment decreases long-term damage after ischemia-reperfusion injury of the lung Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 304 - 312. [Abstract] [Full Text] [PDF]

				J. C. Lee and J. D. Christie Primary Graft Dysfunction Proceedings of the ATS, January 15, 2009; 6(1): 39 - 46. [Abstract] [Full Text] [PDF]

				M. Struber, S. Fischer, J. Niedermeyer, G. Warnecke, B. Gohrbandt, A. Gorler, A. R. Simon, A. Haverich, and J. M. Hohlfeld Effects of exogenous surfactant instillation in clinical lung transplantation: A prospective, randomized trial J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1620 - 1625. [Abstract] [Full Text] [PDF]

				I. Friedrich, J. Borgermann, F. H. Splittgerber, M. Brinkmann, J. C. Reidemeister, R. E. Silber, W. Seeger, R. Schmidt, and A. Gunther Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 335 - 343. [Abstract] [Full Text] [PDF]

				A. Gunther, M. Balser, R. Schmidt, P. Markart, A. Olk, J. Borgermann, F. H. Splittgerber, W. Seeger, and I. Friedrich Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 344 - 354. [Abstract] [Full Text] [PDF]

				J. Li, J. J. Marsh, and R. G. Spragg Effect Of CTP:Phosphocholine Cytidylyltransferase Overexpression on the Mouse Lung Surfactant System Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 709 - 715. [Abstract] [Full Text] [PDF]

				R. J. Novick Innovative techniques to enhance lung preservation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 3 - 5. [Full Text] [PDF]

				G. Maitra, K. Inchley, R. J. Novick, R. A. W. Veldhuizen, J. F. Lewis, and F. Possmayer Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L67 - L74. [Abstract] [Full Text] [PDF]

				J. S. Gammie, D. R. Stukus, S. M. Pham, B. G. Hattler, M. F. McGrath, K. R. McCurry, B. P. Griffith, and R. J. Keenan Effect of ischemic time on survival in clinical lung transplantation Ann. Thorac. Surg., December 1, 1999; 68(6): 2015 - 2019. [Abstract] [Full Text] [PDF]

				J. M. HOHLFELD, E. TIRYAKI, H. HAMM, H. G. HOYMANN, N. KRUG, A. HAVERICH, and H. FABEL Pulmonary Surfactant Activity Is Impaired in Lung Transplant Recipients Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 706 - 712. [Abstract] [Full Text] [PDF]

				J. A. CLEMENTS and M. E. AVERY Lung Surfactant and Neonatal Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S59 - S66. [Full Text] [PDF]